I am so grateful to have joined my first #WalkToEndAlzh. Doing research on AD, it was incredibly meaningful to walk alongside people with the disease and their families, as well as others dedicated to raising awareness and hope.

🚨Thrilled to share our new chapter on the role of precision medicine in obesity management, now part of the SAGES Manual of Metabolic and Bariatric Surgery! Grateful for the opportunity to contribute! Andres Acosta SAGES is in Tampa in 2026! Omar M Ghanem link.springer.com/chapter/10.100…

🚨 Thrilled to share that I will be delivering an oral and a poster presentation at #DDW2025 Digestive Disease Week Proud of our lab’s efforts that resulted in 2 orals and 9 posters! Beyond grateful for the continuing support! Andres Acosta Daniela Hurtado A. M.D., Ph.D. 🇪🇨 Mayo Clinic Gastroenterology & Hepatology UTSW Internal Medicine Chiefs

Thrilled to present my poster at my first Digestive Disease Week #DDW2025. Grateful for all the efforts and support from my lab. Andres Acosta Mayo Clinic Gastroenterology & Hepatology Looking forward to sharing our work in San Diego! 🏖️ 🧬 #GI #DDW

🌍 #WorldObesityDay ⭕ is here! Today, we unite to demand systemic change across health, food, and societal systems. Let’s build healthier futures for everyone—together! 👉 Get involved: worldobesityday.org 📺 Watch: youtu.be/Jy2uIgvs7qs?si… #WOD2025 #ChangingSystems

🌍 Today is #WorldObesityDay ⭕️! Obesity rates are rising—not because of individual choices, but due to failing systems. It’s time for systemic change in health, food, and societal systems. 📢 Join us in calling for action! 👉 worldobesityday.org #WOD2025 #ChangingSystems

Excited to have met with colleagues, friends and mentors from the Precision Medicine for Obesity Program Mayo Clinic Gastroenterology & Hepatology to observe #WorldObesityDay! The Obesity Society World Obesity Andres Acosta Daniela Hurtado A. M.D., Ph.D. 🇪🇨

🧬 NEW STUDY: Obesity’s Massive Health Impact--from my research group, led by the brilliant Jackie Yao. - - - 🚨 In a nationwide study of 270,000+ adults using the All of Us Research Program, obesity was linked to a higher risk of 16 health conditions—with risk increasing by

🚨BREAKING: Semaglutide for MASH: A Step Forward in Metabolic Liver Disease Phase 3 data just released (NEJM 2025): In 800 patients with biopsy-confirmed MASH and fibrosis stage 2–3, semaglutide 2.4 mg weekly delivered impressive results at 72 weeks (compared to placebo):

Excited to share 24 abstracts, lectures and symposium with two plenaries this week. Thanks to all the amazing collaborators Digestive Disease Week Mayo Clinic Gastroenterology & Hepatology American Gastroenterological Association (AGA) ASGE GI Endoscopy phenomixsciences

At Digestive Disease Week The next fronteir for obesity phenotypes requires to elucidate the unique microbial signature of each phenotype. Diego Anazco, MD (rising start) showing the data today. Fascinating findings!

Celebrating our amazing team! Great year of many accomplishments! This team makes it happen! So proud of everyone! Mayo Clinic Mayo Clinic Gastroenterology & Hepatology Digestive Disease Week

SO grateful to have crossed paths with essential humans on my last day at #DDW2025 🖤📸 Proud of @SucapaAraya ✨who outstandingly presented our #IBD research to many visitors📈🙏🏽 My heart is full ❤️‍🩹 Love this community and LOVE GI #AGAGastroSquad American Gastroenterological Association (AGA)

Wrapping up #DDW2025 day 4 with two great abstracts from our team. alex showing the conservative expression of #GLP1 in the ileum and colon and ⁦Maria Antonia Espinosa⁩ describing weight recurrence after RYGB with a high CTS-GRS. ⁦Mayo Clinic Gastroenterology & Hepatology⁩ ⁦American Gastroenterological Association (AGA)⁩

Excited to present our work at my first #DDW2025. Inspired by the brilliant sessions and grateful to connect with amazing people! Grateful to work alongside an incredible team of rising stars in the field who inspire me to keep improving every day!

Excited to share our review on Precision Medicine for Obesity treatment! Mayo Clinic Mayo Clinic Gastroenterology & Hepatology

New op-ed from Violeta Popov, MD PhD: #MASLD can be prevented by treating obesity, but gaps in Medicaid are preventing access to lifesaving treatment. We need solutions to keep patients healthy. ow.ly/YOYm50WlWmc

Excited to attend and present at my first #ACG2025! Enjoyed reconnecting with old friends and learning more about GI in the warm Phoenix, Arizona ☀️🌵.

Honored to spotlight the work of my lab at ObesityWeek®! Grateful to share this experience with my team in the vibrant Atlanta 🎡🏙️. Deeply thankful for the support and mentorship Andres Acosta and Daniela Hurtado A. M.D., Ph.D. 🇪🇨 Mayo Clinic #OW2025